CLINICAL TRIALS PROFILE FOR GLIPIZIDE
✉ Email this page to a colleague
All Clinical Trials for GLIPIZIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00094770 ↗ | An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2004-09-01 | The purpose of this investigational study is to determine the safety and effectiveness of an investigational drug in patients with type 2 diabetes mellitus (a specific type of diabetes). |
NCT00095056 ↗ | An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2004-10-01 | The purpose of this study is to determine the safety and tolerability of an investigational drug in patients with Type 2 Diabetes Mellitus (a specific type of diabetes) and Chronic Renal Insufficiency (inadequate kidney function). |
NCT00116831 ↗ | Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes | Completed | GlaxoSmithKline | Phase 3 | 2005-01-01 | The purpose of this study is to test the safety and effectiveness of rosiglitazone against a sulfonylurea in reducing or slowing the development of atherosclerosis in the blood vessels of the heart. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GLIPIZIDE
Condition Name
Clinical Trial Locations for GLIPIZIDE
Trials by Country
Clinical Trial Progress for GLIPIZIDE
Clinical Trial Phase
Clinical Trial Sponsors for GLIPIZIDE
Sponsor Name